Ceftolozane/Tazobactam Activity Against Drug-Resistant Pseudomonas aeruginosa and Enterobacterales Causing Healthcare-Associated Infections in Eight Asian Countries: Report from an Antimicrobial Surveillance Program (2016–2018)

Pfaller M, Shortridge D, Chen WT, Sader H, Castanheira M

Infection and Drug Resistance 2022, 15:6739-6753

Published Date: 22 November 2022